Hopital Europeen Georges Pompidou Begins Clinical Evaluation of BioCurex Cancer Detection Kits
October 23, 2003 08:00 ET
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., Oct. 23, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) is pleased to announce that extensive evaluations of the company's RECAF(tm) cancer detection technologies have...
Breast Cancer Awareness and BioCurex Inc.
October 22, 2003 17:11 ET
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., Oct. 22, 2003 (PRIMEZONE) -- Biocurex Inc. (OTCBB:BOCX) is developing basic techniques using its patented technology that could be applied effectively to assist the...
Biocurex Reports Results on Blood Test for Ovarian Cancer with a Market Potential of $200 Million Dollars; Test Outperforms Current Reference Assay
June 18, 2003 16:21 ET
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., June 18, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announces an estimate of 25% penetration of this $200 million market within the next 3 years via licensing...
BioCurex Starts Clinical Evaluation of Its Cancer Detections Kits With Research Centers And Hospitals In Japan
June 03, 2003 17:01 ET
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., June 3, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announces that it has started an evaluation of the company's RECAF(TM) based cancer detection kits in Japan....
BioCurex Announces New Blood Test For Cancer Detection with 95% Sensitivity, 95% Specificity - Addressing a $2 Billion Market
May 28, 2003 16:55 ET
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., May 28, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announces initial results for its Serum-RECAF(TM) cancer test. A universal cancer marker can be used not only...
Biocurex Announces Appointment of New CEO
May 01, 2003 16:19 ET
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., May 1, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announces that its Board of Directors has appointed Dr. Ricardo Moro-Vidal as Chief Executive Officer of the...
BioCurex Inc.: Introduction of the FDA Cleared Histo-RECAF Technology to Major Drug Companies and Professionals
April 28, 2003 16:01 ET
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., April 28, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announces that the prestigious trade journal IVD Technology (In-vitro Diagnostic Technology) has invited...
BioCurex Announces BioLargo Technologies Inc. Joint Venture with Cryopak Industries Inc.
April 04, 2003 07:00 ET
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., April 4, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) today announced that BioLargo technologies Inc. has negotiated a joint venture marketing agreement with Cryopak...
BioCurex Announces BioLargo Technologies Inc. Joint Venture with Cryopak Industries Inc.
April 03, 2003 16:34 ET
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., April 3, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) today announced that BioLargo technologies Inc. has negotiated a joint venture marketing agreement with Cryopak...
BioCurex Announces a Proposed 3 for 1 Forward Split
March 13, 2003 10:30 ET
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., March 13, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announced today that its Board of Directors unanimously voted to submit to the Company's shareholders a...